In the drug discovery process, the first step is to identify an appropriate 'druggable' target, which can be a iomolecule or a protein receptor that is explicitly associated with a disease condition or pathology. After the target has been identified, the next step involves target validation and the confirmation of its role in the disease progression. This is followed by testing of the target against different small molecule compounds to identify lead compounds which can interact with the target biomolecule and display the potential to either nullify or slow the disease development. Vs Prashansa Agrawal, Drug Discovery and Development: An Insight into Pharmacovigilance.
Last date updated on June, 2014